Effects of combination antihypertensive therapy on intracardiac hemodynamics and blood vessels in patients with coronary heart disease, post-infarction cardiosclerosis and arterial hypertension

Authors

DOI:

https://doi.org/10.14739/2310-1210.2023.4.284248

Keywords:

fixed-dose combination, ACE inhibitor, amlodipine, angiotensin 2 receptor blocker, coronary heart disease, post-infarction cardiosclerosis, blood pressure, left ventricular diastolic function

Abstract

The aim of the work is to assess the effectiveness of prescribing a fixed-dose combination of amlodipine with the ACE inhibitor lisinopril or with the angiotensin 2 receptor blocker valsartan in patients with coronary artery disease, acute coronary syndrome with hypertensive disease regarding the impact on the structural and functional parameters of the heart and extracranial branches of the brachiocephalic arteries.

Materials and methods. General clinical examination of 108 patients with postinfarction cardiosclerosis and hypertension was done within 12 months. The patients were allocated to two groups. Patients in the first group (n = 50) were assigned a fixed-dose combination of lisinopril and amlodipine (20 mg and 5 mg, respectively), and patients in the second group (n = 58) received a fixed-dose combination of valsartan with amlodipine (160 mg and 5 mg, respectively). The patients were monitored for 12 months, including general clinical examinations, measurements of office blood pressure (BP), 24-hour BP monitoring, echo-dopplerographic examination of the heart and brachiocephalic arteries, determination of the composite endpoint. Statistical analysis of the obtained data was performed using Microsoft Excel, IBM SPSS Statistics v.23.

Results. A significant difference in echocardiographic data has been proved (p < 0.05) regarding left ventricle (LV) dimensions in both study groups. A significant decrease in the E/A ratio and an insignificant decrease in E/E’ (p > 0.05) have been found in the first group. When analyzing the indicators of diastolic function in the second group, a highly significant (p < 0.05) decrease in E/A, E/E’, IO of the LA has been revealed; data analysis on the morphofunctional state indicators of the extracranial arteries has shown a CIM reduction and a decrease in PSV and RI.

Conclusions. Prescriptions of the fixed-dose combination of amlodipine with the ACE inhibitor lisinopril was more effective in terms of the LV measurements (p < 0.05) and LV diastolic function as evidenced by decreased E/A, E/E’ and IO of the LA (p < 0.05) as compared to the data in the group of amlodipine with the angiotensin 2 receptor blocker valsartan. Both fixed-dose combinations were effective in reducing the CIM thickness, decreasing PSV and RI when analyzing the morphofunctional state findings of the extracranial arteries.

Author Biographies

M. M. Dolzhenko, Shupyk National Healthcare University of Ukraine, Kyiv

MD, PhD, DSc, Professor, Head of the Department of Cardiology

S. A. Bondarchuk, Shupyk National Healthcare University of Ukraine, Kyiv

MD, Postgraduate student of the Department of Cardiology

L. Ye. Lobach, Shupyk National Healthcare University of Ukraine, Kyiv

MD, PhD, Assistant of the Department of Cardiology

References

Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., Kahan, T., Mahfoud, F., Redon, J., Ruilope, L., Zanchetti, A., Kerins, M., Kjeldsen, S. E., Kreutz, R., Laurent, S., Lip, G. Y. H., … ESC Scientific Document Group (2018). 2018 ESC/ESH Guidelines for the management of arterial hypertension. European heart journal, 39(33), 3021-3104. https://doi.org/10.1093/eurheartj/ehy339

SCORE2-OP working group and ESC Cardiovascular risk collaboration (2021). SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions. European heart journal, 42(25), 2455-2467. https://doi.org/10.1093/eurheartj/ehab312

Ferreira, J. P., Girerd, N., Bozec, E., Machu, J. L., Boivin, J. M., London, G. M., Zannad, F., & Rossignol, P. (2016). Intima-Media Thickness Is Linearly and Continuously Associated With Systolic Blood Pressure in a Population-Based Cohort (STANISLAS Cohort Study). Journal of the American Heart Association, 5(6), e003529. https://doi.org/10.1161/JAHA.116.003529

Takamura, K., Fujimoto, S., Mita, T., Kawaguchi, Y. O., Kurita, M., Kadowaki, S., Kamo, Y., Aoshima, C., Nozaki, Y. O., Takahashi, D., Kudo, A., Hiki, M., Tomizawa, N., Ikeda, F., Satoh, H., Watada, H., & Minamino, T. (2022). Identification of Risk Factors for Coronary Artery Disease in Asymptomatic Patients with Type 2 Diabetes Mellitus. Journal of clinical medicine, 11(5), 1226. https://doi.org/10.3390/jcm11051226

Peters, S., Trümmel, M., Meyners, W., Koehler, B., & Westermann, K. (2005). Valsartan versus ACE inhibition after bare metal stent implantation--results of the VALVACE trial. International journal of cardiology, 98(2), 331-335. https://doi.org/10.1016/j.ijcard.2004.05.062

Kotseva, K., De Backer, G., De Bacquer, D., Rydén, L., Hoes, A., Grobbee, D., Maggioni, A., Marques-Vidal, P., Jennings, C., Abreu, A., Aguiar, C., Badariene, J., Bruthans, J., Castro Conde, A., Cifkova, R., Crowley, J., Davletov, K., Deckers, J., De Smedt, D., De Sutter, J., … EUROASPIRE Investigators* (2019). Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry. European journal of preventive cardiology, 26(8), 824-835. https://doi.org/10.1177/2047487318825350

De Bacquer, D., Ueda, P., Reiner, Ž., De Sutter, J., De Smedt, D., Lovic, D., … for the EUROASPIRE IV and V National Coordinators. (2022). Prediction of recurrent event in patients with coronary heart disease : the EUROASPIRE Risk Model : results from a prospective study in 27 countries in the WHO European region-The EURObservational Research Programme (EORP) of the European Society of Cardiology (ESC). European journal of preventive cardiology, 29(2), 328-339. https://doi.org/10.1093/eurjpc/zwaa128

Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., Isasi, C. R., Jiménez, M. C., Jordan, L. C., Judd, S. E., Lackland, D., Lichtman, J. H., Lisabeth, L., Liu, S., Longenecker, C. T., Mackey, R. H., … American Heart Association Statistics Committee and Stroke Statistics Subcommittee (2017). Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation, 135(10), e146-e603. https://doi.org/10.1161/CIR.0000000000000485

Rea, F., Corrao, G., Merlino, L., & Mancia, G. (2018). Early cardiovascular protection by initial two-drug fixed-dose combination treatment vs. monotherapy in hypertension. European heart journal, 39(40), 3654-3661. https://doi.org/10.1093/eurheartj/ehy420

Salam, A., Kanukula, R., Atkins, E., Wang, X., Islam, S., Kishore, S. P., Jaffe, M. G., Patel, A., & Rodgers, A. (2019). Efficacy and safety of dual combination therapy of blood pressure-lowering drugs as initial treatment for hypertension: a systematic review and meta-analysis of randomized controlled trials. Journal of hypertension, 37(9), 1768-1774. https://doi.org/10.1097/HJH.0000000000002096

Knuuti, J., Wijns, W., Saraste, A., Capodanno, D., Barbato, E., Funck-Brentano, C., Prescott, E., Storey, R. F., Deaton, C., Cuisset, T., Agewall, S., Dickstein, K., Edvardsen, T., Escaned, J., Gersh, B. J., Svitil, P., Gilard, M., Hasdai, D., Hatala, R., Mahfoud, F., … ESC Scientific Document Group (2020). 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. European heart journal, 41(3), 407-477. https://doi.org/10.1093/eurheartj/ehz425

Lang, R. M., Badano, L. P., Mor-Avi, V., Afilalo, J., Armstrong, A., Ernande, L., Flachskampf, F. A., Foster, E., Goldstein, S. A., Kuznetsova, T., Lancellotti, P., Muraru, D., Picard, M. H., Rietzschel, E. R., Rudski, L., Spencer, K. T., Tsang, W., & Voigt, J. U. (2015). Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. European heart journal. Cardiovascular Imaging, 16(3), 233-270. https://doi.org/10.1093/ehjci/jev014

Nagueh, S. F., Smiseth, O. A., Appleton, C. P., Byrd, B. F., 3rd, Dokainish, H., Edvardsen, T., Flachskampf, F. A., Gillebert, T. C., Klein, A. L., Lancellotti, P., Marino, P., Oh, J. K., Popescu, B. A., & Waggoner, A. D. (2016). Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Journal of the American Society of Echocardiography, 29(4), 277-314. https://doi.org/10.1016/j.echo.2016.01.011

Aboyans, V., Ricco, J. B., Bartelink, M. E. L., Björck, M., Brodmann, M., Cohnert, T., Collet, J. P., Czerny, M., De Carlo, M., Debus, S., Espinola-Klein, C., Kahan, T., Kownator, S., Mazzolai, L., Naylor, A. R., Roffi, M., Röther, J., Sprynger, M., Tendera, M., Tepe, G., … ESC Scientific Document Group (2018). 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). European heart journal, 39(9), 763-816. https://doi.org/10.1093/eurheartj/ehx095

Sprynger, M., Rigo, F., Moonen, M., Aboyans, V., Edvardsen, T., de Alcantara, M. L., Brodmann, M., Naka, K. K., Kownator, S., Simova, I., Vlachopoulos, C., Wautrecht, J. C., Lancellotti, P., & EACVI Scientific Documents Committee (2018). Focus on echovascular imaging assessment of arterial disease: complement to the ESC guidelines (PARTIM 1) in collaboration with the Working Group on Aorta and Peripheral Vascular Diseases. European heart journal. Cardiovascular Imaging, 19(11), 1195-1221. https://doi.org/10.1093/ehjci/jey103

North American Symptomatic Carotid Endarterectomy Trial Collaborators, Barnett, H. J. M., Taylor, D. W., Haynes, R. B., Sackett, D. L., Peerless, S. J., Ferguson, G. G., Fox, A. J., Rankin, R. N., Hachinski, V. C., Wiebers, D. O., & Eliasziw, M. (1991). Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. The New England journal of medicine, 325(7), 445-453. https://doi.org/10.1056/NEJM199108153250701

Sayin, B. Y., & Oto, A. (2022). Left Ventricular Hypertrophy: Etiology-Based Therapeutic Options. Cardiology and therapy, 11(2), 203-230. https://doi.org/10.1007/s40119-022-00260-y

Malnick, S. D., & Somin, M. (2007). The VALIDD study. Lancet, 370(9591), 931-932. https://doi.org/10.1016/S0140-6736(07)61434-2

Gupta, A., Mackay, J., Whitehouse, A., Godec, T., Collier, T., Pocock, S., Poulter, N., & Sever, P. (2018). Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up results of a randomised factorial trial. Lancet, 392(10153), 1127-1137. https://doi.org/10.1016/S0140-6736(18)31776-8

Published

2023-07-20

How to Cite

1.
Dolzhenko MM, Bondarchuk SA, Lobach LY. Effects of combination antihypertensive therapy on intracardiac hemodynamics and blood vessels in patients with coronary heart disease, post-infarction cardiosclerosis and arterial hypertension. Zaporozhye Medical Journal [Internet]. 2023Jul.20 [cited 2024Jun.18];25(4):285-91. Available from: http://zmj.zsmu.edu.ua/article/view/284248